摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

benzyl 3-O-benzyl-6-O-hexylsulfonyl-D-glucopyranoside | 1216905-10-0

中文名称
——
中文别名
——
英文名称
benzyl 3-O-benzyl-6-O-hexylsulfonyl-D-glucopyranoside
英文别名
——
benzyl 3-O-benzyl-6-O-hexylsulfonyl-D-glucopyranoside化学式
CAS
1216905-10-0
化学式
C26H36O8S
mdl
——
分子量
508.633
InChiKey
VYEDEHWRVFFBOX-MQPVPCFRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.16
  • 重原子数:
    35.0
  • 可旋转键数:
    14.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    111.52
  • 氢给体数:
    2.0
  • 氢受体数:
    8.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    benzyl 3-O-benzyl-6-O-hexylsulfonyl-D-glucopyranoside二苯基N,N'-二异丙基亚磷酰胺四氮唑叔丁基过氧化氢 作用下, 以 乙腈 为溶剂, 反应 24.0h, 以76%的产率得到benzyl 3-O-benzyl-2,4-bis(dibenzylphosphoryl)-6-O-hexylsulfonyl-D-glucopyranoside
    参考文献:
    名称:
    Development of carbohydrate-derived inhibitors of acid sphingomyelinase
    摘要:
    The acid sphingomyelinase is an emerging drug target, especially for inflammatory lung diseases. Presently, there are no directly-acting potent inhibitors available for cell-based studies. The potent inhibitor phosphatidylinositol-3,5-bisphosphate (PtdIns3,5P2) is not only unsuited for cell culture studies, but also does not provide hints for further structural improvements. In the SAR study described here, we replaced the inositolphosphate moiety by a carbohydrate derivative and the phosphatidic acid residue by an alkyl-sulfone ester. The resulting compound is more active than its parent compound and offers new means for further structural modification. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.11.030
  • 作为产物:
    描述:
    benzyl 3-O-benzyl-D-glucopyranoside2-己基磺酰氯三乙胺 作用下, 以 二氯甲烷 为溶剂, 以31%的产率得到benzyl 3-O-benzyl-6-O-hexylsulfonyl-D-glucopyranoside
    参考文献:
    名称:
    Development of carbohydrate-derived inhibitors of acid sphingomyelinase
    摘要:
    The acid sphingomyelinase is an emerging drug target, especially for inflammatory lung diseases. Presently, there are no directly-acting potent inhibitors available for cell-based studies. The potent inhibitor phosphatidylinositol-3,5-bisphosphate (PtdIns3,5P2) is not only unsuited for cell culture studies, but also does not provide hints for further structural improvements. In the SAR study described here, we replaced the inositolphosphate moiety by a carbohydrate derivative and the phosphatidic acid residue by an alkyl-sulfone ester. The resulting compound is more active than its parent compound and offers new means for further structural modification. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.11.030
点击查看最新优质反应信息